{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:19:16Z","timestamp":1787008756432,"version":"build-2736575974"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Heart Journal"],"DOI":"10.1093\/eurheartj\/ehl209","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T22:47:05Z","timestamp":1156546025000},"page":"2224-2231","source":"Crossref","is-referenced-by-count":37,"title":["Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial"],"prefix":"10.1093","volume":"27","author":[{"given":"F.","family":"Lombardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,8,9]]},"container-title":["European Heart Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T13:10:18Z","timestamp":1485349818000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehl209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,9]]},"references-count":0,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2006,8,9]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehl209","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,9]]}}}